comparemela.com

Latest Breaking News On - Monetary management group inc - Page 1 : comparemela.com

Verition Fund Management LLC Acquires 1,225 Shares of Sempra (NYSE:SRE)

Verition Fund Management LLC boosted its position in shares of Sempra (NYSE:SRE – Free Report) by 0.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 980,067 shares of the utilities provider’s stock after purchasing an additional 1,225 shares during the period. Sempra accounts for approximately 0.6% of Verition Fund Management LLC’s portfolio, making […]

Joseph Group Capital Management Decreases Stake in Pfizer Inc (NYSE:PFE)

Joseph Group Capital Management lowered its position in Pfizer Inc. (NYSE:PFE – Free Report) by 95.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,928 shares of the biopharmaceutical company’s stock after selling 58,387 shares during the period. Joseph Group Capital Management’s holdings in Pfizer were […]

Joseph Group Capital Management Decreases Stake in Pfizer Inc (NYSE:PFE)

Joseph Group Capital Management lowered its position in Pfizer Inc. (NYSE:PFE – Free Report) by 95.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,928 shares of the biopharmaceutical company’s stock after selling 58,387 shares during the period. Joseph Group Capital Management’s holdings in Pfizer were […]

Sempra (NYSE:SRE) Shares Sold by BTG Pactual Global Asset Management Ltd

BTG Pactual Global Asset Management Ltd decreased its stake in Sempra (NYSE:SRE – Free Report) by 23.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,518 shares of the utilities provider’s stock after selling 13,201 shares during the quarter. Sempra makes […]

Taurus Asset Management LLC Sells 73 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Taurus Asset Management LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,054 shares of the biopharmaceutical company’s stock after selling 73 shares during the quarter. Regeneron Pharmaceuticals accounts […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.